Dataset from A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNF Alpha Agents
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00010131
下载链接
链接失效反馈官方服务：
资源简介：
The primary purpose of this study is to evaluate the efficacy of guselkumab treatment in
participants with active Psoriatic Arthritis (PsA) by assessing the reduction in signs and
symptoms of PsA.
创建时间：
2025-02-10
